by Bruce Sylvester: Women who suffer migraines appear to have an increased risk of heart attacks and strokes as well as a higher rate of mortality from cardiovascular… read more.
by Gary Finnegan: Cholesterol levels – the most common risk factor for heart attacks – have decreased in northern Sweden over the last 20 years. Since medication only… read more.
by Gary Finnegan: Hospital admissions for first-time stroke increased in young adults in Denmark during the past two decades, according to new research in Journal of the American Heart… read more.
by Bruce Sylvester: Gait speed is an independent predictor of adverse outcomes after cardiac surgery, researchers reported on May 11, 2016 in JAMA Cardiology.
by Gary Finnegan: The Chinese population continues to have a high rate of salt intake, fuelling concerns about rising risks of high blood pressure and stroke. The main… read more.
by Bruce Sylvester: In high income countries, loneliness and social isolation appear to increase the risk of stroke or coronary artery disease by about 30 per cent, researchers… read more.
by Bruce Sylvester: Treatment with cardioselective beta-blockers appears to reduce the risk of exacerbations in chronic obstructive pulmonary disease (COPD), and it is especially effective in preventing COPD… read more.
by Bruce Sylvester: For correction of atrial fibrillation, radiofrequency ablation and cryoballoon ablation show similar results for efficacy and safety, researchers reported on April 4, 2016 at the… read more.
by Bruce Sylvester: In intermediate-risk patients with symptomatic severe aortic stenosis, transcatheter aortic-valve replacement (TAVR) is similar to surgical aortic-valve replacement with respect to death or disabling stroke.
by Bruce Sylvester: Rhythm control and rate control are similarly effective in treating post-operative atrial fibrillation, researchers reported on April 4, 2016 at the American College of Cardiology… read more.
by Bruce Sylvester: Rosuvastatin treatment more effectively prevents cardiovascular events than candesartan plus hydrochlorothiazide among subjects who do not have cardiovascular disease and who received cholesterol-lowering treatment.
by Bruce Sylvester: Tissue plasminogen activator (tPA) treatment with the clot-busting drug alteplase appears to be an effective way to decrease mortality in intraventricular hemorrhage, a catastrophic type… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
